Relation Therapeutics
PrivateLast Round
Corporate Funding
Dec 9, 2025
Total Funding Raised
$76.33M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Relation Therapeutics is a biotechnology company that discovers and develops medicines by leveraging its proprietary 'Lab-in-the-Loop' platform which integrates active-graph machine learning, single-cell multi-omics, and genomic data derived from human patient tissue.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Relation Therapeutics Comparables
Compare Relation Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valo Health | 88% | |
| Insitro | 87% | |
| BenevolentAI | 86% | |
Relation Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 9, 2025 | ||||
| Strategic | Dec 10, 2024 | ||||
| Seed | Mar 14, 2024 | ||||
| Early Stage VC | Jan 19, 2024 | ||||
| Seed | Jun 9, 2022 | ||||
Seed | Jul 1, 2021 |
Key People
Founding team and executive leadership
Relation Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Corporate Funding, Seed |
| Deerfield Management | Seed |
| Firstminute Capital | Seed |
| Khosla Ventures | Seed |
| Magnetic Ventures | Seed, Corporate Funding |
| NVentures | Corporate Funding |
| The Bill & Melinda Gates Foundation Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 1, 2026
PatchDNA model recognized at NeurIPS AI4D3 workshop.
- Jan 1, 2026
Initiated in 2026 to address fibrosis and osteoarthritis.
Relation Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Relation Therapeutics's valuation, stock price, and market status.